TerminatedNot Applicable

Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion

Stopped: Investigational drugs no longer available

Norway14 participantsStarted 2012-01

Plain-language summary

In this study we will investigate the effect of intranasal corticosteroid therapy, which is known to reduce mucosal inflammation and nasal blockage, on asthmatic symptoms.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * asthma (according to British Thoracic Society guideline) * \>18 years Exclusion Criteria: * pregnancy * systemic disease with nasal manifestations * cancer of the nose * currently receiving cancer therapy * previous nose surgery

What they're measuring

forced expiratory volume

Timeframe: up to 12 weeks

Trial details

NCT IDNCT01562093

SponsorSt. Olavs Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-06

View on ClinicalTrials.gov More Asthma trials